Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul;67(7):733-734.
doi: 10.4103/indianjpsychiatry_355_25. Epub 2025 Jul 15.

Levetiracetam induced obsessive-compulsive disorder in a patient of epilepsy

Affiliations

Levetiracetam induced obsessive-compulsive disorder in a patient of epilepsy

P Snehabala et al. Indian J Psychiatry. 2025 Jul.
No abstract available

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Similar articles

References

    1. Shukla G, Gupta A, Agarwal P, Poornima S. Behavioral effects and somnolence due to levetiracetam versus oxcarbazepine—A retrospective comparison study of North Indian patients with refractory epilepsy. Epilepsy Behav. 2016;64:216–8. - PubMed
    1. Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, Charney DS. The Yale-Brown obsessive compulsive scale: I. Development, use, and reliability. Archives of general psychiatry. 1989;46:1006–11. - PubMed
    1. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239–45. - PubMed
    1. Whiteside SP, Port JD, Deacon BJ, Abramowitz JS. A magnetic resonance spectroscopy investigation of obsessive-compulsive disorder and anxiety. Psychiatry Res. 2006;146:137–47. - PubMed
    1. Doobay M, Sharma V, Eccles H. Antiseizure medication-induced obsessive-compulsive disorder and tic disorder: A pragmatic review. Expert Rev Neurother. 2022;22:721–31. - PubMed

LinkOut - more resources